COPD Foundation
Bruce Miller has extensive work experience in the pharmaceutical industry. Bruce began their career at GSK in 2007, where they held the position of Clinical Development Director & Senior Fellow for 14 years until 2021. In 2022, they joined the COPD Foundation as the Chief Scientific Officer.
Bruce Miller obtained a Ph.D. in Pharmacology and Toxicology from the University of North Carolina at Chapel Hill between 1984 and 1989. In addition, they have obtained several certifications, including "Biomedical Responsible Conduct of Research" from CITI Program, A Division of BRANY in April 2021, "Biomedical Research - Basic/Refresher" from CITI Program, A Division of BRANY in March 2021, and "Clinicians" from CITI Program, A Division of BRANY in February 2021.
This person is not in any offices
COPD Foundation
1 followers
Chronic Obstructive Pulmonary Disease (COPD) is a preventable and treatable disease. The COPD Foundation was established to improve the lives of people with COPD, bronchiectasis, and nontuberculous mycobacterial (NTM) lung disease through initiatives that expand services and speed innovations which will make treatment more effective and affordable. We do this through scientific research, education, advocacy, and awareness with the goal of disease prevention, slowed progression, and ultimately a cure.